华兰生物：参股公司收到药品注册受理通知书

Core Viewpoint - The company announced that its subsidiary, Hualan Gene Engineering Co., Ltd., has received the acceptance notice for the production registration application of Dexamethasone Injection from the National Medical Products Administration [1] Group 1 - The drug is classified as a Class 3 biological product for therapeutic use [1] - The specification of the drug is 120mg (1.7ml) per bottle [1] - The applicant for the drug registration is Hualan Gene Engineering Co., Ltd. [1]